$WELNF·8-K

Integrated Wellness Acquisition Corp · Mar 2, 4:05 PM ET

Compare

Integrated Wellness Acquisition Corp 8-K

Research Summary

AI-generated summary

Updated

Integrated Wellness Acquisition Corp Approves Business Combination with Btab

What Happened
Integrated Wellness Acquisition Corp (WELNF) reported that its shareholders approved the proposed business combination with Btab Ecommerce Group, Inc. at a meeting held on December 8, 2025. On February 23, 2026 the company filed an Extension Proxy Statement for an extraordinary meeting (the Extension Meeting) scheduled for March 12, 2026 to seek approval to amend its charter to extend the deadline to complete a business combination from March 16, 2026 to September 16, 2026.

Key Details

  • Shareholder approval of the Business Combination with Btab occurred on December 8, 2025.
  • Extension Proxy Statement filed February 23, 2026; Extension Meeting scheduled for March 12, 2026 at 11:00 a.m. ET.
  • Proposed extension would move the deadline to complete a business combination from March 16, 2026 to September 16, 2026.
  • Estimated per-share redemption price as of December 31, 2025: approximately $12.91 (including accrued interest, less taxes).
  • Redemption mechanics: public shareholders can submit or withdraw redemption requests; to ensure shares submitted previously are redeemed in connection with the Extension, shareholders must instruct the transfer agent (Continental Stock & Transfer Company) by the Extension redemption deadline. Transfer agent email: spacredemptions@continentalstock.com.

Why It Matters
The December 8 approval moves the proposed merger with Btab forward, but the company is also seeking shareholder approval to extend the deadline to close the transaction to September 16, 2026. That extension vote matters because redemptions by public shareholders (and the resulting cash remaining in the company’s trust) can affect whether the merger closes and whether Nasdaq listing requirements are met. The filing also contains forward-looking statements and identifies risks (including the risk the transaction may not close), so investors should review the Business Combination and Extension proxy statements and the company’s SEC filings for full details before making decisions.

Loading document...